# Zinc Sulfate for Human Papillomavirus (HPV)

> **NCT03404310** · NA · TERMINATED · sponsor: **Corewell Health West** · enrollment: 21 (actual)

## Conditions studied

- Human Papilloma Virus

## Interventions

- **DIETARY_SUPPLEMENT:** Zinc Sulfate
- **OTHER:** Placebo (Gelatin Tablet)

## Key facts

- **NCT ID:** NCT03404310
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-24
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404310, "Zinc Sulfate for Human Papillomavirus (HPV)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03404310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*